Press Releases United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-08 pm EDT			5-day change	1st Jan Change
316.9 ^USD	+0.74%		-0.66%	+44.11%

Jul. 08	UBS Adjusts Price Target on United Therapeutics to $370 From $300, Maintains Buy Rating	MT
Jul. 01	United Therapeutics Corporation(NasdaqGS:UTHR) added to Russell 1000 Defensive Index	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment	05:35am	AQ
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors	Jun. 27	BU
Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension	Jun. 26	AQ
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer	Jun. 06	AQ
United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	Jun. 05	BU
Manufacturers Are "Winning" In The 340B Drug Discount Dispute	May. 31	AQ
United Therapeutics: Q1 Earnings Snapshot	May. 01	AQ
United Therapeutics Corporation Reports First Quarter 2024 Financial Results	May. 01	BU
UNITED THERAPEUTICS ANNOUNCES WORLD'S FIRST SUCCESSFUL XENOTHYMOKIDNEY TRANSPLANT	Apr. 25	AQ
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant	Apr. 24	BU
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024	Apr. 24	BU
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference	Apr. 16	BU
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation	Mar. 26	BU
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program	Mar. 25	BU
The Printed Future Of Transplantology, Or How Science Fiction Became Reality	Mar. 19	AQ
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024	Mar. 05	BU
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 27	BU
United Therapeutics: Q4 Earnings Snapshot	Feb. 21	AQ
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 21	BU
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process	Feb. 21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases United Therapeutics Corporation

Equities

UTHR

US91307C1027

Press Releases

Filters